Synonyms: AZD 9567 | AZD-9567 | compound 15 [PMID: 29424542] | example 1 [WO2016046260A1] [2]
Compound class:
Synthetic organic
Comment: AZD9567 is a synthetic, selective glucocorticoid receptor (GR) partial agonist [1]. It was designed to offer an improved side-effect profile compared to conventional full agonist GR anti-inflammatory dugs. AZD9567 is one of the chemical structures claimed in patent WO2016046260A1 [2].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
In a cellular transactivation (TA) assay AZD9567 exhibits partial agonism (EC50 11nM, with agonist efficacy of 36%), and in the TA antagonist assay it has an IC50 of 160nM (antagonist efficacy of 56%) [1]. AZD9567 is highly selective for GR compared to the progesterone, mineralocorticoid, androgen and estrogen (α and β) receptors, as well as vs. a number of other proteins tested. Although AZD9567 is a partial agonist in transactivation assays, it mediates full GR translocation into the nucleus. Orally AZD9567 elicits potent anti-inflammatory effects in rat model of joint inflammation [1]. |
Selectivity at nuclear hormone receptors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|